HIGHLIGHTS
- who: Inmaculada Hernandez and colleagues from the Division of Clinical Pharmacy, University of California, San Diego, Skaggs School of Pharmacy and have published the research work: COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data, in the Journal: PLOS ONE of 20/Oct/2022
- what: The authors aimed to quantify changes in new diagnoses of AF following the onset of the COVID-19 pandemic. Previous US studies have reported significant decreases in the number of hospitalizations and emergency room visits for common chronic conditions related to the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.